好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Trends in Coverage for Disease Modifying Therapies for Multiple Sclerosis in Medicare Part D
Practice, Policy, and Ethics
P3 - (-)
161
Authors/Disclosures
Daniel Hartung, PharmD, MPH (Oregon State University / Oregon Health & Science University)
PRESENTER
Mr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alkermes. Mr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Mr. Hartung has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Humana. Mr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for US DOJ. Mr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with NMSS.
No disclosure on file
Dennis N. Bourdette, MD, FAAN Dr. Bourdette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Magellan Health Care. Dr. Bourdette has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctor's Inc. Dr. Bourdette has stock in Authobahn Therapeutics. Dr. Bourdette has received intellectual property interests from a discovery or technology relating to health care.